Peptilogics Company
Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery
Investors
Connections from
Founded Date:
2013-01-01
Technology:
Anti-infective Drugs
Funding Status:
Early Stage Venture
Total Funding:
44051761.0
Employee Number:
11-50
Headquarters:
Pittsburgh, Pennsylvania, United States
Last Funding Date:
2022-01-05
Investors Number:
11.0
Last Funding Type:
Grant
Estimated Revenue:
$1M to $10M
Industry:
Early Drug Development